In this study of non-GCB DLBCL patients, the relationship between the expression of NF-κB/p65 protein and clinicopathological parameters, and the prognostic value of NF-κB/p65 protein expression were explored. Here, NFKB1 is linked to diffuse large B-cell lymphoma.